サマリー

A-Methapred (methylprednisolone sodium for injection, USP) sterile powder は、有効成分としてコハク酸メチルプレドニゾロンナトリウムを含有しています。コハク酸メチルプレドニゾロンナトリウム（USP）は、白色またはほぼ白色の無臭の吸湿性非晶質固体として存在します。水とアルコールに非常に溶けやすく、クロロホルムには溶けず、アセトンに非常にわずかに溶ける。
市場分析および洞察。A-メタプレッドの世界市場
COVID-19の大流行により、世界のA-Methapredの市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルに再調整されると予測されています。この健康危機による経済変化を十分に考慮し、2021年にA-Methapred世界市場の％を占めるInjectionは、2028年までに100万米ドルの価値を持ち、ポストCOVID-19期間に修正された％のCAGRで成長すると予測されます。一方、病院セグメントは、この予測期間を通して％CAGRに変更されています。

中国のA-Methapredの市場規模は2021年に100万米ドル、米国と欧州のA-Methapredはそれぞれ100万米ドル、100万米ドルと評価されています。2021年の米国の割合は％、中国と欧州はそれぞれ％、％で、中国の割合は2028年には％に達すると予測され、分析期間を通じてCAGRは％であることがわかりました。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％である。ヨーロッパのA-Methapredの状況については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%となっています。
A-Methapredの世界的な主要メーカーには、ファイザー、アボット、マイラン、テバなどがあります。2021年には、世界の上位5社が売上高で約 %のシェアを占めています。

世界のA-Methapredの範囲とセグメント
A-Methapred市場は、タイプ別および用途別に分類されます。世界のA-Methapred市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになります。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
インジェクション
粉体
その他
用途別セグメント
病院
ドラッグストア

会社別
ファイザー
アボット社
マイラン
テバ

地域別
北米
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 Study Coverage
1.1 A-Methapred Product Introduction
1.2 Market by Type
1.2.1 Global A-Methapred Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Injection
1.2.3 Powder
1.2.4 Other
1.3 Market by Application
1.3.1 Global A-Methapred Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global A-Methapred Sales Estimates and Forecasts 2017-2028
2.2 Global A-Methapred Revenue Estimates and Forecasts 2017-2028
2.3 Global A-Methapred Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global A-Methapred Sales by Region
2.4.1 Global A-Methapred Sales by Region (2017-2022)
2.4.2 Global Sales A-Methapred by Region (2023-2028)
2.5 Global A-Methapred Revenue by Region
2.5.1 Global A-Methapred Revenue by Region (2017-2022)
2.5.2 Global A-Methapred Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global A-Methapred Sales by Manufacturers
3.1.1 Global Top A-Methapred Manufacturers by Sales (2017-2022)
3.1.2 Global A-Methapred Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of A-Methapred in 2021
3.2 Global A-Methapred Revenue by Manufacturers
3.2.1 Global A-Methapred Revenue by Manufacturers (2017-2022)
3.2.2 Global A-Methapred Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by A-Methapred Revenue in 2021
3.3 Global A-Methapred Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global A-Methapred Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global A-Methapred Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global A-Methapred Sales by Type
4.1.1 Global A-Methapred Historical Sales by Type (2017-2022)
4.1.2 Global A-Methapred Forecasted Sales by Type (2023-2028)
4.1.3 Global A-Methapred Sales Market Share by Type (2017-2028)
4.2 Global A-Methapred Revenue by Type
4.2.1 Global A-Methapred Historical Revenue by Type (2017-2022)
4.2.2 Global A-Methapred Forecasted Revenue by Type (2023-2028)
4.2.3 Global A-Methapred Revenue Market Share by Type (2017-2028)
4.3 Global A-Methapred Price by Type
4.3.1 Global A-Methapred Price by Type (2017-2022)
4.3.2 Global A-Methapred Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global A-Methapred Sales by Application
5.1.1 Global A-Methapred Historical Sales by Application (2017-2022)
5.1.2 Global A-Methapred Forecasted Sales by Application (2023-2028)
5.1.3 Global A-Methapred Sales Market Share by Application (2017-2028)
5.2 Global A-Methapred Revenue by Application
5.2.1 Global A-Methapred Historical Revenue by Application (2017-2022)
5.2.2 Global A-Methapred Forecasted Revenue by Application (2023-2028)
5.2.3 Global A-Methapred Revenue Market Share by Application (2017-2028)
5.3 Global A-Methapred Price by Application
5.3.1 Global A-Methapred Price by Application (2017-2022)
5.3.2 Global A-Methapred Price Forecast by Application (2023-2028)
6 North America
6.1 North America A-Methapred Market Size by Type
6.1.1 North America A-Methapred Sales by Type (2017-2028)
6.1.2 North America A-Methapred Revenue by Type (2017-2028)
6.2 North America A-Methapred Market Size by Application
6.2.1 North America A-Methapred Sales by Application (2017-2028)
6.2.2 North America A-Methapred Revenue by Application (2017-2028)
6.3 North America A-Methapred Market Size by Country
6.3.1 North America A-Methapred Sales by Country (2017-2028)
6.3.2 North America A-Methapred Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe A-Methapred Market Size by Type
7.1.1 Europe A-Methapred Sales by Type (2017-2028)
7.1.2 Europe A-Methapred Revenue by Type (2017-2028)
7.2 Europe A-Methapred Market Size by Application
7.2.1 Europe A-Methapred Sales by Application (2017-2028)
7.2.2 Europe A-Methapred Revenue by Application (2017-2028)
7.3 Europe A-Methapred Market Size by Country
7.3.1 Europe A-Methapred Sales by Country (2017-2028)
7.3.2 Europe A-Methapred Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific A-Methapred Market Size by Type
8.1.1 Asia Pacific A-Methapred Sales by Type (2017-2028)
8.1.2 Asia Pacific A-Methapred Revenue by Type (2017-2028)
8.2 Asia Pacific A-Methapred Market Size by Application
8.2.1 Asia Pacific A-Methapred Sales by Application (2017-2028)
8.2.2 Asia Pacific A-Methapred Revenue by Application (2017-2028)
8.3 Asia Pacific A-Methapred Market Size by Region
8.3.1 Asia Pacific A-Methapred Sales by Region (2017-2028)
8.3.2 Asia Pacific A-Methapred Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America A-Methapred Market Size by Type
9.1.1 Latin America A-Methapred Sales by Type (2017-2028)
9.1.2 Latin America A-Methapred Revenue by Type (2017-2028)
9.2 Latin America A-Methapred Market Size by Application
9.2.1 Latin America A-Methapred Sales by Application (2017-2028)
9.2.2 Latin America A-Methapred Revenue by Application (2017-2028)
9.3 Latin America A-Methapred Market Size by Country
9.3.1 Latin America A-Methapred Sales by Country (2017-2028)
9.3.2 Latin America A-Methapred Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa A-Methapred Market Size by Type
10.1.1 Middle East and Africa A-Methapred Sales by Type (2017-2028)
10.1.2 Middle East and Africa A-Methapred Revenue by Type (2017-2028)
10.2 Middle East and Africa A-Methapred Market Size by Application
10.2.1 Middle East and Africa A-Methapred Sales by Application (2017-2028)
10.2.2 Middle East and Africa A-Methapred Revenue by Application (2017-2028)
10.3 Middle East and Africa A-Methapred Market Size by Country
10.3.1 Middle East and Africa A-Methapred Sales by Country (2017-2028)
10.3.2 Middle East and Africa A-Methapred Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer A-Methapred Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer A-Methapred Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Overview
11.2.3 Abbott A-Methapred Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott A-Methapred Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Recent Developments
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Overview
11.3.3 Mylan A-Methapred Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mylan A-Methapred Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan Recent Developments
11.4 Teva
11.4.1 Teva Corporation Information
11.4.2 Teva Overview
11.4.3 Teva A-Methapred Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Teva A-Methapred Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 A-Methapred Industry Chain Analysis
12.2 A-Methapred Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 A-Methapred Production Mode & Process
12.4 A-Methapred Sales and Marketing
12.4.1 A-Methapred Sales Channels
12.4.2 A-Methapred Distributors
12.5 A-Methapred Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 A-Methapred Industry Trends
13.2 A-Methapred Market Drivers
13.3 A-Methapred Market Challenges
13.4 A-Methapred Market Restraints
14 Key Findings in The Global A-Methapred Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer